Page last updated: 2024-09-03

2-pyrrolino-dox and Cancer of Kidney

2-pyrrolino-dox has been researched along with Cancer of Kidney in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, B; Engel, JB; Gaiser, T; Halmos, G; Keller, G; Nagy, A; Schally, AV1

Other Studies

1 other study(ies) available for 2-pyrrolino-dox and Cancer of Kidney

ArticleYear
Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-01, Volume: 11, Issue:15

    Topics: Animals; Antineoplastic Agents; Binding Sites; Blotting, Western; Carcinoma, Renal Cell; Cell Differentiation; Cell Line, Tumor; DNA, Complementary; Doxorubicin; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Kinetics; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptides; Protein Binding; Pyrroles; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2005